Crescent Biopharma, Inc. (CBIO) vs Bright Minds Biosciences Inc. (DRUG)
A side-by-side comparison of Crescent Biopharma, Inc. and Bright Minds Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CBIO
Crescent Biopharma, Inc.
$13.94HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
DRUG
Bright Minds Biosciences Inc.
$49.79HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CBIO vs DRUG
growth of $100 · dividends reinvested · last 6yCBIO -85.4% (-27.4%/yr)DRUG +84.4% (+10.7%/yr)DRUG compounded faster over this window
Log scale — wide-divergence pair
CBIO DRUG
CBIO vs DRUG: by the numbers
- •CBIO is the larger company ($518M vs $487M market cap).
- •Both run net losses; DRUG's is the smaller (0.00% vs -1371.51% net margin).
Metrics side by side
Valuation
| Metric | CBIO | DRUG |
|---|---|---|
| P/S ratio | 43.57 | N/A |
| P/B ratio | 3.25 | 2.25 |
Profitability
| Metric | CBIO | DRUG |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -1407.52% | 0.00% |
| Net margin | -1371.51% | 0.00% |
| ROE | -99.83% | -8.21% |
| ROIC | -102.59% | -13.15% |
Growth (annualized)
| Metric | CBIO | DRUG |
|---|---|---|
| Revenue CAGR (5Y) | 39.89% | N/A |
| Total return CAGR (5Y) | -24.40% | 6.76% |
Frequently asked
- How have CBIO and DRUG total returns compared?
- Over the past 5 years, CBIO delivered -24.40% and DRUG delivered 6.76% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Crescent Biopharma ROEBright Minds Biosciences ROECrescent Biopharma operating marginBright Minds Biosciences operating marginCrescent Biopharma revenue growthBright Minds Biosciences revenue growthCrescent Biopharma free cash flowBright Minds Biosciences free cash flow
Crescent Biopharma & Bright Minds Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.